Delivery Order SPE2DR25D1100-SPE2DR26FCV2D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $6,633.02 to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 5, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $14,902.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of October 29, 2025. This is a firm fixed-price, non-set-aside contract executed on October 28, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $8,521.98 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 8, 2025. This is a firm fixed-price, non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the products will be performed. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $15,954.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in 60-dose inhalers. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $60,688.79 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in 60-dose units. This firm fixed price, non-set-aside delivery order was awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $13,326.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a respiratory maintenance medication supplied in a 60-dose package. This competitive, non-set-aside contract award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, reflecting a rapid fulfillment timeline typical of pharmaceutical supply orders. The contract employs firm fixed pricing and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $13,395.37 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, competitively awarded delivery order was issued on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $20,089.16 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination pulmonary medication supplied in a 60-dose inhaler. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and employs firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV2DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose unit. This firm fixed-price, non-set-aside contract was awarded on December 16, 2025, with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor for the Defense Logistics Agency's medical supply chain, AmerisourceBergen serves critical healthcare needs across military systems, the Defense Health Agency, and the U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products and medical commodities, with this delivery order exemplifying its role as a key supplier of specialty medications and therapeutics to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $68.8k | 12/15/25 |